Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Jones

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Vaccine|October 22, 2008
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg virusesThomas W Geisbert, Kathleen M Daddario-Dicaprio, Joan B Geisbert, et al.
The Journal of Infectious Diseases|October 12, 2011
Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirusDarryl Falzarano, Friederike Feldmann, Allen Grolla, et al.
Plos Pathogens|January 24, 2007
Effective post-exposure treatment of Ebola infectionHeinz Feldmann, Steven M Jones, Kathleen M Daddario-DiCaprio, et al.
Lancet (London, England)|May 3, 2006
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessmentKathleen M Daddario-DiCaprio, Thomas W Geisbert, Ute Ströher, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Taxonomy-free fecal microbiome profiles enable robust prediction of immunotherapy response and toxicity in melanomaAnastasia Lucas, McKenna Reale, Yuri I Wolf, et al.
The Journal of Infectious Diseases|May 6, 2010
Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, AngolaPaul Roddy, Sara L Thomas, Benjamin Jeffs, et al.
Plos Pathogens|December 2, 2008
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primatesThomas W Geisbert, Kathleen M Daddario-Dicaprio, Mark G Lewis, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2017
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 InhibitorsAlice W Tsai, Colleen F McNeil, Joshua R Leeman, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Vaccine|October 22, 2008
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg virusesThomas W Geisbert, Kathleen M Daddario-Dicaprio, Joan B Geisbert, et al.
The Journal of Infectious Diseases|October 12, 2011
Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirusDarryl Falzarano, Friederike Feldmann, Allen Grolla, et al.
Plos Pathogens|January 24, 2007
Effective post-exposure treatment of Ebola infectionHeinz Feldmann, Steven M Jones, Kathleen M Daddario-DiCaprio, et al.
Lancet (London, England)|May 3, 2006
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessmentKathleen M Daddario-DiCaprio, Thomas W Geisbert, Ute Ströher, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Taxonomy-free fecal microbiome profiles enable robust prediction of immunotherapy response and toxicity in melanomaAnastasia Lucas, McKenna Reale, Yuri I Wolf, et al.
The Journal of Infectious Diseases|May 6, 2010
Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, AngolaPaul Roddy, Sara L Thomas, Benjamin Jeffs, et al.
Plos Pathogens|December 2, 2008
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primatesThomas W Geisbert, Kathleen M Daddario-Dicaprio, Mark G Lewis, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infectionsChristopher P Locher, Steven M Jones, Brian L Hanzelka, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2017
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosisMichael P Clark, Tiansheng Wang, Emanuele Perola, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 InhibitorsAlice W Tsai, Colleen F McNeil, Joshua R Leeman, et al.
Pageof 8